Presenter: Dr. James McCormack Dr. Mike Allan Samantha Moe PharmD
In episode 572, James and Mike invite Samantha Moe back to the podcast to go over the evidence around the safety and effectiveness of the monoclonal antibodies used to reduce the risk of respiratory syncytial virus (RSV) infections in infants. We go over all the numbers for hospitalizations and death so you can make evidence-informed…
CFP Podcast: Graphic medicine
BS Medicine Episode #583: Reducing the risk associated with risk calculators – PART II
BS Medicine Episode #582: Reducing the risk associated with risk calculators
Presenter(s):
Dr. James McCormack Dr. Mike Allan Samantha Moe PharmD
Please provide any additional comments (optional).